Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations

Author(s):  Jasti Bhaskara R, Saraf Poonam

Issue:  May/Jun 2011 - Volume 15, Number 3
View All Articles in Issue

Page(s):  259-261

Download in electronic PDF format for $65

Abstract:  The compatibility of furosemide with 17 secondary drugs was studied to determine suitability for Y-site coadministration of the drug combinations. The drugs were tested at their standardized concentrations by visual observation for signs of physical incompatibilities. The secondary drugs were either tested undiluted or diluted in 5% dextrose injection or 0.9% sodium chloride injection as specified. Furosemide (10 mg/mL) was mixed with each of the secondary drugs in equal volume, and the mixture was observed for precipitation and turbidity visible to the unaided eye at 0, 4, and 24 hours after mixing. The pH was monitored over 24 hours for any significant fluctuations. The stability of furosemide was determined in combination with sodium bicarbonate over a 24-hour duration by quantifying, using spectophotometric measurements at the wavelength of 278 nm. Of the 17 secondary drugs evaluated, seven drugs showed incompatibility with furosemide resulting in the formation of gross turbid precipitates upon mixing. Dopamine hydrochloride and magnesium sulfate did not show instantaneous physical incompatibility but showed drug precipitation between 0 to 4 hours. The pH measurements did not show any significant changes in the studied drug combinations. The stability of furosemide with sodium bicarbonate at the tested standard concentrations was established since the concentrations measured up to 24 hours were within 10% of the initial value. Thus furosemide is unsuitable for Y-site coadministration with amiodarone hydrochloride, esmolol hydrochloride, labetalol hydrochloride, dobutamine hydrochloride, diltiazem hydrochloride, dopamine hydrochloride, and magnesium sulfate at their standardized concentrations. Coadministration of furosemide with sodium bicarbonate, norepinephrine bitartrate, phenylephrine hydrochloride, calcium gluconate, procainamide hydrochloride, nitroglycerin, epinephrine hydrochloride, heparin sodium, vasopressin, and insulin, at the standardized concentration, was found to be compatible.

Related Keywords: Bhaskara R. Jasti, PhD, Poonam Saraf, furosemide, parenteral preparations, intravenous administration, compatibility, drug mixtures


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Jasti Bhaskara R
, Saraf Poonam
May/Jun 2011
Pg. 259-261

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana
, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Nov/Dec 2022
Pg. 522-526

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R
, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Sep/Oct 2007
Pg. 426-432

Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A
, Saenz Christopher
Jul/Aug 2002
Pg. 311-315

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions